Synovis Life Technologies (SYNO) Stock Price, News & Analysis

Synovis Life Technologies, Inc. (Synovis) is a medical device company. The Company develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. Its products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools. The Company operates in three segments: the surgical business, the microsurgical business, and the Ortho & Wound business. Its surgical business develops, manufactures, markets, and sells implantable biomaterial products and surgical tools. Its surgical business products include Peri-Strips, Tissue Guard, Veritas, and Surgical Tools. The Company’s microsurgical business develops, manufactures, markets, and sells devices serving the niche market of microsurgery. In February 2012, Baxter International Inc. acquired Synovis.